| Product Code: ETC13236062 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Adult Vaccine Market was valued at USD 18.7 Billion in 2024 and is expected to reach USD 44.6 Billion by 2031, growing at a compound annual growth rate of 13.00% during the forecast period (2025-2031).
The Global Adult Vaccine Market is experiencing significant growth driven by increasing awareness about the importance of adult immunization, rising prevalence of infectious diseases, and government initiatives promoting vaccination programs. The market is characterized by a wide range of vaccines targeting various diseases such as influenza, hepatitis, human papillomavirus, and pneumococcal diseases among others. Factors such as the aging population, expanding healthcare infrastructure, and advancements in vaccine technologies are further propelling market growth. Key players in the market are investing in research and development activities to introduce innovative vaccines and expand their product portfolios. Regions like North America and Europe dominate the market, but emerging economies in Asia-Pacific and Latin America are also witnessing rapid growth due to improving healthcare access and rising disposable incomes.
The Global Adult Vaccine Market is experiencing growth due to increasing awareness about the importance of adult immunization and the rising prevalence of infectious diseases. Key trends include the development of new vaccines targeting diseases such as influenza, shingles, and human papillomavirus. There is also a growing emphasis on vaccination programs for older adults and pregnant women to prevent serious health complications. Opportunities in the market lie in expanding vaccination coverage among adults, especially in developing regions, and increasing collaboration between healthcare providers and vaccine manufacturers to improve access and affordability. Additionally, advancements in vaccine technology, such as the use of adjuvants and novel delivery methods, are expected to drive innovation and market expansion in the coming years.
The Global Adult Vaccine Market faces several challenges, including low awareness among adults about the importance of vaccinations, limited access to vaccines, issues with vaccine storage and distribution, and varying regulations and reimbursement policies across different countries. Furthermore, there is a lack of comprehensive vaccination programs targeting adults, leading to suboptimal vaccination rates in this demographic. The perception that vaccines are primarily for children also hinders the growth of the adult vaccine market. Additionally, vaccine hesitancy and misinformation pose significant challenges in convincing adults to get vaccinated. Overcoming these obstacles will require concerted efforts from healthcare providers, policymakers, and vaccine manufacturers to address gaps in education, accessibility, and public health communication strategies.
The Global Adult Vaccine Market is primarily being driven by increasing awareness about the importance of vaccination in preventing infectious diseases among adults, especially in the wake of recent global health crises such as the COVID-19 pandemic. Additionally, the rising geriatric population and the resulting increase in chronic diseases have contributed to a growing demand for adult vaccines. Government initiatives and campaigns promoting adult immunization, along with advancements in vaccine technology and development, are also key drivers of market growth. Furthermore, the expanding travel and tourism industry has led to a greater focus on vaccines for preventing travel-related diseases among adults. Overall, these factors are driving the expansion of the Global Adult Vaccine Market as more individuals and healthcare providers recognize the benefits of vaccination in maintaining public health.
Government policies related to the Global Adult Vaccine Market vary by country but generally focus on promoting vaccination coverage, ensuring vaccine safety and efficacy, and addressing healthcare disparities. Many governments have implemented vaccination programs targeting adults, especially vulnerable populations such as the elderly, healthcare workers, and those with chronic conditions. Some countries also regulate vaccine pricing, procurement, distribution, and administration to ensure affordability and accessibility. Additionally, government policies often include public awareness campaigns, surveillance systems to monitor vaccine-preventable diseases, and research funding to support vaccine development. Overall, government involvement in the adult vaccine market aims to improve public health outcomes, prevent disease outbreaks, and reduce healthcare costs associated with vaccine-preventable illnesses.
The Global Adult Vaccine Market is expected to witness significant growth in the coming years due to increasing awareness about preventive healthcare measures, rising prevalence of infectious diseases in adults, and government initiatives promoting adult vaccination programs. The market is projected to expand with advancements in vaccine technology, a growing geriatric population, and the introduction of new vaccines targeting various diseases such as influenza, HPV, and shingles. Additionally, the ongoing COVID-19 pandemic has highlighted the importance of vaccination in adults, leading to a surge in demand for adult vaccines globally. Key players in the market are focusing on research and development activities to launch innovative vaccines, further driving market growth. Overall, the Global Adult Vaccine Market is poised for robust expansion in the foreseeable future.
In the Global Adult Vaccine Market, North America is the largest regional market due to high awareness and adoption rates of adult vaccination. Europe follows closely behind with a strong emphasis on preventive healthcare. Asia is a rapidly growing market driven by increasing healthcare infrastructure and government initiatives. The Middle East and Africa region shows potential for growth with rising healthcare spending and focus on immunization programs. Latin America is also experiencing growth, particularly in countries like Brazil and Mexico, as a result of expanding healthcare access and increasing awareness about the importance of adult vaccination. Overall, the global adult vaccine market is seeing opportunities for expansion across all regions, driven by factors such as aging populations, increasing disease burden, and growing emphasis on preventative healthcare.
Global Adult Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Adult Vaccine Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Adult Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Global Adult Vaccine Market - Industry Life Cycle |
3.4 Global Adult Vaccine Market - Porter's Five Forces |
3.5 Global Adult Vaccine Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Adult Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Adult Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Global Adult Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.9 Global Adult Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
4 Global Adult Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Adult Vaccine Market Trends |
6 Global Adult Vaccine Market, 2021 - 2031 |
6.1 Global Adult Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Adult Vaccine Market, Revenues & Volume, By Subunit, 2021 - 2031 |
6.1.3 Global Adult Vaccine Market, Revenues & Volume, By mRNA, 2021 - 2031 |
6.1.4 Global Adult Vaccine Market, Revenues & Volume, By Inactivated, 2021 - 2031 |
6.1.5 Global Adult Vaccine Market, Revenues & Volume, By Live attenuated, 2021 - 2031 |
6.1.6 Global Adult Vaccine Market, Revenues & Volume, By Viral Vector, 2021 - 2031 |
6.2 Global Adult Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Adult Vaccine Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 Global Adult Vaccine Market, Revenues & Volume, By Nasal, 2021 - 2031 |
6.2.4 Global Adult Vaccine Market, Revenues & Volume, By Prenteral, 2021 - 2031 |
6.3 Global Adult Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Adult Vaccine Market, Revenues & Volume, By Viral Diseases, 2021 - 2031 |
6.3.3 Global Adult Vaccine Market, Revenues & Volume, By Bacterial Vaccines, 2021 - 2031 |
6.3.4 Global Adult Vaccine Market, Revenues & Volume, By Cancer Vaccines, 2021 - 2031 |
6.3.5 Global Adult Vaccine Market, Revenues & Volume, By Allergy Vaccines, 2021 - 2031 |
6.4 Global Adult Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Adult Vaccine Market, Revenues & Volume, By Adult, 2021 - 2031 |
6.4.3 Global Adult Vaccine Market, Revenues & Volume, By Pediatric, 2021 - 2031 |
7 North America Adult Vaccine Market, Overview & Analysis |
7.1 North America Adult Vaccine Market Revenues & Volume, 2021 - 2031 |
7.2 North America Adult Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Adult Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Adult Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 North America Adult Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.6 North America Adult Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
8 Latin America (LATAM) Adult Vaccine Market, Overview & Analysis |
8.1 Latin America (LATAM) Adult Vaccine Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Adult Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Adult Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Adult Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.5 Latin America (LATAM) Adult Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
8.6 Latin America (LATAM) Adult Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
9 Asia Adult Vaccine Market, Overview & Analysis |
9.1 Asia Adult Vaccine Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Adult Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Adult Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Adult Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.5 Asia Adult Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
9.6 Asia Adult Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
10 Africa Adult Vaccine Market, Overview & Analysis |
10.1 Africa Adult Vaccine Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Adult Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Adult Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Adult Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.5 Africa Adult Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
10.6 Africa Adult Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
11 Europe Adult Vaccine Market, Overview & Analysis |
11.1 Europe Adult Vaccine Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Adult Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Adult Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Adult Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.5 Europe Adult Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
11.6 Europe Adult Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
12 Middle East Adult Vaccine Market, Overview & Analysis |
12.1 Middle East Adult Vaccine Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Adult Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Adult Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Adult Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Adult Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.5 Middle East Adult Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
12.6 Middle East Adult Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
13 Global Adult Vaccine Market Key Performance Indicators |
14 Global Adult Vaccine Market - Export/Import By Countries Assessment |
15 Global Adult Vaccine Market - Opportunity Assessment |
15.1 Global Adult Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Adult Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Adult Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.4 Global Adult Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
15.5 Global Adult Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
16 Global Adult Vaccine Market - Competitive Landscape |
16.1 Global Adult Vaccine Market Revenue Share, By Companies, 2024 |
16.2 Global Adult Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |